Open AccessABCG2, CD44 and SOX9 are increased with the acquisition of drug resistance and involved in cancer stem cell activities in head and neck squamous cell carcinoma cells
Author(s) -
K. Murakami,
Naoki Umemura,
Makoto Adachi,
Masahiro Motoki,
Emika Ohkoshi
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11658
Subject(s) - cancer stem cell , cd44 , stem cell , stem cell marker , abcg2 , biology , head and neck squamous cell carcinoma , cancer research , cancer cell , cisplatin , cancer , side population , cell , microbiology and biotechnology , head and neck cancer , atp binding cassette transporter , chemotherapy , biochemistry , genetics , transporter , gene